Forensic Aspect of Association of Low-density Lipoprotein and Retinopathy in Diabetic Patients

Authors

  • Pradeep kumar Yadav
  • Sachin Kumar Giri
  • Rajiv Ratan Singh
  • Sachin Kumar Tripathi

DOI:

https://doi.org/10.37506/ijfmt.v17i4.19963

Keywords:

Diabetic patients, Diabetic retinopathy, Low-density lipoprotein, Forensic retinopathy, etc.

Abstract

Introduction: Around 10% of people with diabetes are at risk of losing their eyesight due to diabetic retinopathy,
which is a leading cause of blindness globally. Numerous studies have shown that limiting the incidence and
progression of diabetic retinopathy requires thorough treatment of the risk factors for the disease in situations
involving diabetic patients who have had retinopathy, forensic specialists are frequently requested to review
medical data and offer expert testimony. In such circumstances, physicians may investigate the patient’s medical
history, taking into account their LDL levels and other risk factors, to see if medical malpractice or carelessness
contributed to the development of retinopathy.
Aims: The objective is to develop medical provider guidelines, estimate the prospective association between lowdensity
lipoprotein (LDL) and the risk of retinopathy in diabetic patients with type 2 diabetes, and look into any
possible role for malpractice or negligence on the part of medical professionals.
Methods: This was a cross-sectional analysis of all 300 samples collected from patients diagnosed with diabetic
retinopathy at the Dr. Ram Manohar Lohia Institute of Medical Sciences Lucknow. Using univariate, bivariate, and
multivariate analyses, retinal results were associated with blood lipid levels.
Result: In diabetic patients with retinopathy, LDL values were considerably greater than in those without
retinopathy (p 0.001). Studying the forensic aspects of the relationship between LDL and diabetic patients’
retinopathy is crucial because it can enhance patient outcomes and guard against malpractice and mistakes in
medicine.
Conclusion: Low-density lipoprotein cholesterol is a sensitive target marker to foretell cardiovascular events as
well as the requirement for laser therapy in individuals with hypercholesterolemia and diabetic retinopathy. The
judicial system’s capacity to establish responsibility and pay damages in such situations may be affected by the use
of LDL levels as a biomarker for predicting the development of retinopathy.

Author Biographies

  • Pradeep kumar Yadav

    Assistant Professor, Department of Forensic Medicine and Toxicology, Dr. Ram Manohar Lohia Institute
    Lucknow

  • Sachin Kumar Giri

    Senior Resident Department of Medicine, Dr. RML Institute of Medical Sciences Lucknow,
    India, Lucknow, India

  • Rajiv Ratan Singh

    Professor (Jr), Department of Emergency Medicine, Dr.RML Institute of Medical Sciences Lucknow, India, Lucknow, India

  • Sachin Kumar Tripathi

    Scientific Assistant, Toxicology Department of Forensic Medicine & Toxicology, King George’s Medical University, Lucknow, Uttar Pradesh

Downloads

Published

2023-10-16

How to Cite

Forensic Aspect of Association of Low-density Lipoprotein and Retinopathy in Diabetic Patients. (2023). Indian Journal of Forensic Medicine & Toxicology, 17(4), 127-133. https://doi.org/10.37506/ijfmt.v17i4.19963